A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
7 Hills Pharma, LLC
7 Hills Pharma, LLC
Exelixis
Neonc Technologies, Inc.
Fudan University
City of Hope Medical Center
University of Pittsburgh
Bristol-Myers Squibb
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Bristol-Myers Squibb
National Institutes of Health Clinical Center (CC)
Incyte Corporation
GERCOR - Multidisciplinary Oncology Cooperative Group
Seattle Project Corporation
Incyte Corporation
Gritstone bio, Inc.
Xencor, Inc.
Persephone Biosciences
Emory University
Gritstone bio, Inc.
Gritstone bio, Inc.
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Gary Onik MD